A micromethod prothrombin time for oral anticoagulant control

Area of Science:

• Clinical Chemistry
• Hematology
• Thrombosis Research

Background:

• Oral anticoagulant therapy requires regular monitoring to ensure efficacy and safety.
• Conventional prothrombin time (PT) testing involves venous blood collection and laboratory processing.
• A need exists for simpler, more accessible PT monitoring methods.

Purpose of the Study:

• To describe and evaluate a novel capillary prothrombin time method.
• To assess the reliability and convenience of the capillary method for managing oral anticoagulant therapy.
• To determine the correlation between capillary and conventional plasma prothrombin ratios.

Main Methods:

• A capillary prothrombin time method was developed utilizing Australasian Reference Thromboplastin (A.R.T.).
• The method was applied to monitor oral anticoagulant therapy in 59 patients over 225 occasions.
• Capillary prothrombin ratios were compared against conventional plasma prothrombin ratios.

Main Results:

• The capillary prothrombin time method proved to be reliable for monitoring oral anticoagulant therapy.
• The method was found to be convenient for both patients and healthcare providers.
• A significant correlation was established between the capillary prothrombin ratio and the conventional plasma prothrombin ratio.

Conclusions:

• The described capillary prothrombin time method is a viable and effective tool for the control of oral anticoagulant therapy.
• This method offers a reliable and convenient alternative to conventional plasma-based PT testing.
• The strong correlation supports the clinical utility of capillary PT measurements in anticoagulant management.